Intervention Protocol

Sulpiride dose for schizophrenia

  1. Emtithal Rezk1,*,
  2. Husam Aldeen Mohammad2,
  3. Tarek Al Refai3,
  4. Lina Mashoosh3

Editorial Group: Cochrane Schizophrenia Group

Published Online: 13 JUN 2012

DOI: 10.1002/14651858.CD009846

How to Cite

Rezk E, Mohammad HA, Refai TA, Mashoosh L. Sulpiride dose for schizophrenia (Protocol). Cochrane Database of Systematic Reviews 2012, Issue 6. Art. No.: CD009846. DOI: 10.1002/14651858.CD009846.

Author Information

  1. 1

    Al-Mowasat Hospital, Infectious Diseases Department, Damascus, Syrian Arab Republic

  2. 2

    Al-Mowasat Hospital, Department of Psychiatry, Damascus, Syrian Arab Republic

  3. 3

    Ministry of Health, Syrian National Poison Centre, Damascus, Syrian Arab Republic

*Emtithal Rezk, Infectious Diseases Department, Al-Mowasat Hospital, 27 Al Zahrawi Street, Damascus University, Damascus, Syrian Arab Republic.

Publication History

  1. Publication Status: New
  2. Published Online: 13 JUN 2012




  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

The primary objective is to determine dose response relationships for sulpiride in the treatment of schizophrenia and schizophrenia-like psychoses.